X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs FRESENIUS KABI ONCO. - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE FRESENIUS KABI ONCO. CADILA HEALTHCARE/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 17.4 22.1 78.5% View Chart
P/BV x 3.9 3.1 125.2% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 CADILA HEALTHCARE   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
FRESENIUS KABI ONCO.
Mar-13
CADILA HEALTHCARE/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs558176 317.0%   
Low Rs36279 460.5%   
Sales per share (Unadj.) Rs116.337.7 308.6%  
Earnings per share (Unadj.) Rs17.95.1 350.8%  
Cash flow per share (Unadj.) Rs23.16.7 344.0%  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs85.442.5 200.8%  
Shares outstanding (eoy) m1,023.74158.23 647.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.03.4 117.1%   
Avg P/E ratio x25.725.0 103.0%  
P/CF ratio (eoy) x19.918.9 105.0%  
Price / Book Value ratio x5.43.0 180.0%  
Dividend payout %19.60-   
Avg Mkt Cap Rs m470,66420,135 2,337.6%   
No. of employees `00011.81.2 1,026.0%   
Total wages/salary Rs m18,545703 2,637.2%   
Avg. sales/employee Rs Th10,072.75,176.2 194.6%   
Avg. wages/employee Rs Th1,569.1610.4 257.1%   
Avg. net profit/employee Rs Th1,547.7699.6 221.2%   
INCOME DATA
Net Sales Rs m119,0495,963 1,996.5%  
Other income Rs m1,13218 6,288.9%   
Total revenues Rs m120,1815,981 2,009.4%   
Gross profit Rs m28,4751,430 1,991.1%  
Depreciation Rs m5,388258 2,089.2%   
Interest Rs m911-26 -3,503.8%   
Profit before tax Rs m23,3081,216 1,916.5%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m5,644342 1,649.3%   
Profit after tax Rs m18,292806 2,269.8%  
Gross profit margin %23.924.0 99.7%  
Effective tax rate %24.228.1 86.1%   
Net profit margin %15.413.5 113.7%  
BALANCE SHEET DATA
Current assets Rs m82,0055,102 1,607.4%   
Current liabilities Rs m60,7202,385 2,545.5%   
Net working cap to sales %17.945.6 39.3%  
Current ratio x1.42.1 63.1%  
Inventory Days Days73150 48.7%  
Debtors Days Days98113 86.8%  
Net fixed assets Rs m83,7035,148 1,625.9%   
Share capital Rs m1,024158 647.3%   
"Free" reserves Rs m86,4216,556 1,318.3%   
Net worth Rs m87,4456,732 1,299.0%   
Long term debt Rs m25,551952 2,683.4%   
Total assets Rs m180,65310,388 1,739.1%  
Interest coverage x26.6-45.8 -58.1%   
Debt to equity ratio x0.30.1 206.6%  
Sales to assets ratio x0.70.6 114.8%   
Return on assets %10.67.5 141.6%  
Return on equity %20.912.0 174.7%  
Return on capital %22.014.6 150.6%  
Exports to sales %074.5 0.0%   
Imports to sales %024.8 0.0%   
Exports (fob) Rs mNA4,441 0.0%   
Imports (cif) Rs mNA1,477 0.0%   
Fx inflow Rs m42,6835,298 805.7%   
Fx outflow Rs m11,2421,772 634.4%   
Net fx Rs m31,4413,525 891.8%   
CASH FLOW
From Operations Rs m9,1931,274 721.5%  
From Investments Rs m-9,737-1,204 808.6%  
From Financial Activity Rs m515-196 -262.6%  
Net Cashflow Rs m-29-126 23.0%  

Share Holding

Indian Promoters % 74.8 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 8.3 0.3 2,766.7%  
FIIs % 5.9 9.6 61.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 9.1 120.9%  
Shareholders   44,069 42,599 103.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   ABBOTT INDIA  NATCO PHARMA  DIVIS LABORATORIES  PFIZER  ALKEM LABORATORIES  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Get Ready for Record Highs(Podcast)

Globally, Traders were left scrambling after the Federal Reserve forecast zero interest-rate hikes this year and just one in 2020.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Up 274.4% (Quarterly Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

For the quarter ended June 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (up 274.4% YoY). Sales on the other hand came in at Rs 29 bn (up 29.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 50.4% (Quarterly Result Update)

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 50.4% YoY). Sales on the other hand came in at Rs 33 bn (up 28.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Mar 22, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS